Home ›
Entities
› academia
› Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Research article (Advances in Therapy, 2023) · cited 11× · AI/ML
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Summary
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma is a scholarly article[1].
Key Facts
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma. Retrieved May 24, 2026, from https://4ort.xyz/entity/comparative-effectiveness-of-teclistamab-versus-real-world-physicians-choice-of-therapy-in-locommotion-and-momment-in-tr
MLA“Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/comparative-effectiveness-of-teclistamab-versus-real-world-physicians-choice-of-therapy-in-locommotion-and-momment-in-tr.
BibTeX@misc{4ortxyz_comparative-effectiveness-of-teclistamab-versus-real-world-physicians-choice-of-therapy-in-locommotion-and-momment-in-tr_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma}}, year = {2026}, url = {https://4ort.xyz/entity/comparative-effectiveness-of-teclistamab-versus-real-world-physicians-choice-of-therapy-in-locommotion-and-momment-in-tr}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma — https://4ort.xyz/entity/comparative-effectiveness-of-teclistamab-versus-real-world-physicians-choice-of-therapy-in-locommotion-and-momment-in-tr (retrieved 2026-05-24)
